S.B. No. 2429, titled the Texas Genomic Act of 2025, aims to enhance the security of genetic information for residents of Texas. The bill introduces a new chapter in the Health and Safety Code, which includes definitions relevant to the legislation, such as "company," "genome sequencer," and "foreign adversary." It establishes strict regulations prohibiting medical facilities, research facilities, companies, or nonprofit organizations from using genome sequencing technologies produced by foreign adversaries or selling genomic information during bankruptcy proceedings. Additionally, the bill mandates that all genomic data be stored within the United States and outlines requirements for data security, including encryption and access restrictions.

The legislation also provides for civil penalties of $10,000 for violations and allows residents harmed by improper handling of their genomic data to pursue a private cause of action for damages. The attorney general is granted investigative authority to enforce compliance and may impose sanctions on entities that violate the provisions of the act. The bill is set to take effect on September 1, 2025, and applies to causes of action that accrue on or after that date, with specific provisions for bankruptcy filings.

Statutes affected:
Introduced: ()
Senate Committee Report: ()